Globe Life (NYSE:GL – Get Free Report) is expected to issue its Q4 2025 results after the market closes on Wednesday, February 4th. Analysts expect Globe Life to post earnings of $3.44 per share and revenue of $1.5319 billion for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, February 5, 2026 at 11:00 AM ET.
Globe Life Stock Down 0.6%
GL stock opened at $137.23 on Wednesday. The business’s 50-day moving average price is $137.83 and its 200-day moving average price is $136.95. The stock has a market cap of $10.92 billion, a P/E ratio of 9.94 and a beta of 0.48. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. Globe Life has a twelve month low of $109.38 and a twelve month high of $147.83.
Globe Life Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Monday, January 5th will be paid a dividend of $0.27 per share. The ex-dividend date is Monday, January 5th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s payout ratio is 7.83%.
Insider Buying and Selling at Globe Life
Institutional Trading of Globe Life
A number of large investors have recently made changes to their positions in GL. Laird Norton Wetherby Wealth Management LLC lifted its holdings in shares of Globe Life by 2.2% in the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock valued at $646,000 after acquiring an additional 99 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Globe Life by 7.8% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 2,528 shares of the company’s stock valued at $361,000 after purchasing an additional 183 shares during the period. CYBER HORNET ETFs LLC bought a new stake in shares of Globe Life in the 2nd quarter valued at approximately $28,000. Brown Advisory Inc. boosted its holdings in shares of Globe Life by 6.3% in the 2nd quarter. Brown Advisory Inc. now owns 3,986 shares of the company’s stock worth $495,000 after purchasing an additional 236 shares during the period. Finally, MUFG Securities EMEA plc purchased a new position in shares of Globe Life in the 2nd quarter worth approximately $31,000. 81.61% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on GL. Evercore ISI lowered Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target for the company. in a research note on Tuesday, January 6th. Weiss Ratings cut Globe Life from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Wednesday, January 14th. Wells Fargo & Company decreased their target price on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research note on Friday, October 24th. Piper Sandler restated an “overweight” rating and issued a $167.00 price target on shares of Globe Life in a research note on Friday, November 21st. Finally, TD Cowen reaffirmed a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. Seven analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $166.22.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Featured Articles
- Five stocks we like better than Globe Life
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The biggest scam in the history of gold markets is unwinding
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
